Each component has distinct pharmacokinetic properties, with phentermine having a 20-hour half-life and topiramate extending to 21 hours, supporting twice-daily dosing regimens (Hendricks et al., Obesity, 2014)
But the real-world breastfeeding data is still limited , and we dont have strong research tracking infant outcomes across different breastfeeding situations
The authors call for long-term studies to assess the impact of GLP-1 RAs on cardiovascular safety, bone health, growth, pubertal development, and other long-term outcomes, helping define their role in the long-term management of pediatric metabolic disease
Injection Site Reactions Patients taking TRESIBA may experience injection site reactions, including injection site hematoma, pain, hemorrhage, erythema, nodules, swelling, discoloration, pruritus, warmth, and injection site mass
Telomeres are structures at the very ends of our chromosomes